Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 2009 Apr 01; 69(7):3021-31.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cell Line, Tumor
Cisplatin
ErbB Receptors
Gene Dosage
Head and Neck Neoplasms
Humans
Immunohistochemistry
Indoles
Mice
Mice, Nude
Mutation
Piperazines
Protein Kinase Inhibitors
Protein Structure, Tertiary
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-met
Receptors, Growth Factor
RNA, Small Interfering
Signal Transduction
Sulfonamides
Transfection
Xenograft Model Antitumor Assays
authors with profiles
Mark W. Lingen
Soundararajan Krishnaswamy
Ravi Salgia
Ramasamy Jagadeeswaran
Ezra Cohen
Everett E. Vokes